Wednesday, April 05, 2006

Vioxx death - Latest Vioxx Trial In Jury's Hands 


Latest Vioxx Trial In Jury's Hands 
This is a transcript of the Midday Update Business View video report.
Source: www.forbes.com

Merck Improves First Quarter Outlook 
Merck Improves First Quarter Outlook on Strong Sales of Zocor Cholesterol Drug
Source: abcnews.go.com

Vioxx jury hears closing arguments 
A jury hearing the case of two men who attribute their heart attacks to the pain-reliever Vioxx heard starkly different summaries of the evidence yesterday, with a Merck & Co. Inc. lawyer defending its handling of the drug and a plaintiff's attorney ripping the company as desperate and dishonest.
Source: www.myrtlebeachonline.com

Merck hikes profit outlook 
NEW YORK (Reuters) - Merck & Co. Inc. MRK.N raised its first-quarter earnings forecast on Tuesday due to strong sales of its Zocor cholesterol drug and lower-than-expected expenses recorded in the period.
Source: go.reuters.com

Merck Lifts Quarterly Forecast 
The company keeps its full-year projection intact.
Source: www.thestreet.com

0 Comments:

Post a Comment

<< Home